Further, the IGF-I assay method, the need for assay-specific reference intervals and the impact of biological confounders need to be accounted for when considering IGF-I as a component of precision medicine in the management of GH deficiencies. The gene discussed is GH1; the disease is hyperinsulinemic hypoglycemia, familial, 4.